Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2005-07-12
2005-07-12
Smith, Lynette R. F. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C424S197110, C435S243000, C435S245000
Reexamination Certificate
active
06916478
ABSTRACT:
The invention relates to novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, methods for preparing same, and their use in the prevention and treatment of infectious diseases.
REFERENCES:
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 4971801 (1990-11-01), Urban
patent: 5000958 (1991-03-01), Fountain et al.
patent: 5186941 (1993-02-01), Callahan et al.
patent: 5223412 (1993-06-01), Wight et al.
patent: 5242947 (1993-09-01), Cherskey et al.
patent: 5858698 (1999-01-01), Armstrong et al.
patent: 0 061 253 (1982-09-01), None
patent: 0 564 689 (1993-10-01), None
patent: 43005011 (1968-02-01), None
patent: 1708351 (1992-01-01), None
patent: WO 90/06696 (1990-06-01), None
patent: WO 91/09616 (1991-07-01), None
patent: WO 91/11174 (1991-08-01), None
patent: WO 92/05194 (1992-04-01), None
patent: WO 93/22423 (1993-11-01), None
patent: WO 94/04677 (1994-03-01), None
patent: WO 94/08021 (1994-04-01), None
patent: WO 95/23211 (1995-08-01), None
Newland, et al.,Vaccine, 10:766-776 (1992).
Mills, et al.,Vaccine, 6:116-122 (1988).
Tijhaar, et al.,Vaccine, 12:1004-1011 (1994).
Wills, et al.,J. of Virol., 68:6605-6618 (1994).
Tan and Worobec,FEMS Microbial. Letts., 106:281-286 (1993).
Bergmann, et al.,Infect. Immun., 57:2187-2195 (1989).
Bernadsky, et al.,J. Bacteriol., 176:5225-5232 (1994).
Kadurugamuwa, et al.,Antimicrob. Agents Chemother., 37:715-721 (1993).
Lightfoot and Lam,J. Bacteriol., 173:5624-5630 (1991).
Martin and Beveridge,Antimicrob. Agents Chemother., 29:1079-1087 (1986).
Rivera, et al.,J. Bacteriol., 170:512-521 (1988).
Berk, et al.,Infect. Immun., 55:1728-1730 (1987).
Vasil, et al.,Antibiot. Chemother., 44:34-47 (1991).
Ingram, et al.,Can. J. Microbiol., 19:1407-1415 (1973).
Poole and Hancock,FEMS Microbiol. Letts., 16:25-29 (1983).
Hastie, et al.,Infect. Immun., 40:506-513, (1983).
Kessler, et al.,J. Biol. Chem., 268:7503-7508 (1993).
Lazdusniski, et al.,Biochemie, 72:147-156 (1990).
Duoung, et al.,Gene, 121:47-54 (1992).
Guzzo, et al.,J. Bacteriol., 173:5290-5297 (1991).
Hamood, et al.,Infect. Immun., 60:510-517 (1992).
Kadurugamuwa, et al.,J. Bacteriol., 175:5798-5805 (1993).
Kadurugamuwa, et al.,Infect. Immun., 59:3463-3471 (1991).
Beveridge,ASM News, 61:125-130 (1995).
Guzman, et al.,Infect. Immun., 59:4391-4397 (1991).
Kadurugamuwa, et al., Abstract and Poster, 94th ASM, Las Vegas, May 23-27, 1994.
Kadurugamuwa, et al., Abstract ICAAC, Orlando, Florida, Oct. 4-7, 1994.
Kadurugamuwa et al., Abstract and Poster, 95th ASM General Meeting, Wash., DC, May 21-25, 1995.
Beveridge, CBDN Projects Annual Report, Group 2D, Aug. 1993.
Kadurugamuwa, et al.,J. Bacteriol., 177: 14, 3998-4008 (1995).
Tetz, et al., “Ultrastructure of the surface film of bacterial colonies,”Journal of General Microbiology, vol. 139, pp. 855-858 (1993).
Beveridge Terry J.
Kadurugamuwa Jagath L.
Bryan Cave LLP
Smith Lynette R. F.
University of Guelph
Zeman Robert A.
LandOfFree
Vaccines and pharmaceutical compositions using membrane... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines and pharmaceutical compositions using membrane..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines and pharmaceutical compositions using membrane... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3432920